Eribulin Mesylate is an anti-cancer drug used to treat various malignancies, including breast cancer and liposarcoma. It works by inhibiting cancer cell division, effectively blocking tumor growth. Its significance in cancer therapy lies in its ability to manage advanced stages of these diseases. In summary, Eribulin Mesylate is essential for treating certain types of cancer.
Eribulin Mesylate inhibits microtubule dynamics, preventing cancer cells from completing mitosis and thereby blocking tumor growth.